American Society of Gene and Cell Therapy (ASGCT) General Meeting
Each year, the ASGCT general meeting brings together research and industry leaders to present and discuss recent advances in gene and cell therapies. Takara Bio is excited to be attending ASGCT 2019 from April 29–May 2, 2019 in Washington, DC. Our highlights include:
Poster: "Smartphone-based titration of lentiviral vectors"
Our iOS- and Android-compatible smartphone app analyzes a simple, two-step lateral flow assay to quantify lentiviral vector preparations in just 10 minutes. Easily monitor and optimize lentiviral production processes to ensure consistency and confidence in downstream applications.
Poster: "Streamlined genome engineering: identifying successful homologous recombination events using a fluorescence-based screening method"
Detect successful homologous recombination events in your genome editing workflows, independent of insertion length (from single-nucleotide substitutions to longer sequences) or surrounding targeted genomic loci—both in edited populations as well as in clones from 96-well plates.
We're looking forward to seeing you at the meeting. In the meantime, we invite you to reach out to our scientists with any questions or requests via the "talk to a scientist" link below.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2019 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.